Entrada Therapeutics TRDA
NASDAQ TRDA
$5.44 +0.19 (+3.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entrada Therapeutics (TRDA) EV to CFO (2023)

Updated

Entrada Therapeutics' EV to CFO was 3.13 in Q4 2023, down 23.3% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) EV to CFO (2023) Analysis & Trends

From Q1 2023 onward, Entrada Therapeutics has reported EV to CFO for 4 quarters.

  • Quarterly EV to CFO has moved between 1.94 (Q1 2023) and 4.08 (Q3 2023) over five years.
  • Per Business Quant data, TRDA's EV to CFO in the three quarters before Q4 2023 was 4.08 (Q3 2023), 3.73 (Q2 2023) and 1.94 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Entrada Therapeutics 205.54 Mn -172.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 3.13
Sep 30, 2023 4.08
Jun 30, 2023 3.73
Mar 31, 2023 1.94
API Access

Entrada Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TRDA&period=max&api_key=YOUR_API_KEY